abirateron stada 500 mg filmtabletta
stada arzneimittel ag - abirateron-acetát -
abiraterone sandoz 500 mg filmtabletta
sandoz hungária kft. - abirateron-acetát -
abiraterone sandoz 1000 mg filmtabletta
sandoz hungária kft. - abirateron-acetát -
abiraterone richter 500 mg filmtabletta
richter gedeon nyrt. - abirateron-acetát -
abirateron zentiva 250 mg tabletta
zentiva, k.s. (csehország) - abirateron-acetát -
abirateron zentiva 500 mg filmtabletta
zentiva, k.s. (csehország) - abirateron-acetát -
abiraterone g.l. 500 mg filmtabletta
g.l. pharma gmbh - abirateron-acetát -
abiraterone qilu 250 mg tabletta
qilu pharma spain s.l. - abirateron-acetát -
abiraterone qilu 500 mg filmtabletta
qilu pharma spain s.l. - abirateron-acetát -
abiraterone mylan
mylan ireland limited - abirateron-acetát - prosztatikus daganatok - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.